BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

PHAR upcoming catalysts

Pharming Technologies B.V.: 1 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (1 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 2 readout(s) and 1 FDA event(s). Subscribe to PHAR (.ics).

Drugs: Leniolisib

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-11-30 est.P3Pharming Technologies B.V. PHARNCT05438407 Pediatric Patients Aged 4 to 11 Years With APDSAPDSactive not recruiting15

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
2026-09-11FDA approvalapprovedPHARMING PHARJOENJAApproved 2026-09-11: JOENJA (NDA217759 SUPPL6)

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-08-12P2Pharming Technologies B.V. PHARNCT06897358 Leniolisib for Immune Dysregulation in CVIDCommon Variable Immunodeficiency (CVID)completed27
2026-06-23P2Pharming Technologies B.V. PHARNCT06549114 Leniolisib for Immune Dysregulation in PIDsPrimary Immunodeficiency Disorders (PIDs)completed13

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.